These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 35789605)
1. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery. Zhang X; Li J; Liu T; Zhao M; Liang B; Chen H; Zhang Z Dis Markers; 2022; 2022():4369329. PubMed ID: 35789605 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M Gene; 2020 Jun; 742():144549. PubMed ID: 32184169 [TBL] [Abstract][Full Text] [Related]
3. Key genes involved in nonalcoholic steatohepatitis improvement after bariatric surgery. Chen X; Deng SZ; Sun Y; Bai Y; Wang Y; Yang Y Front Endocrinol (Lausanne); 2024; 15():1338889. PubMed ID: 38469144 [TBL] [Abstract][Full Text] [Related]
4. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure. Li G; Lu Z; Chen Z Front Immunol; 2024; 15():1424308. PubMed ID: 39351239 [TBL] [Abstract][Full Text] [Related]
5. Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis. Jiang ZY; Zhou Y; Zhou L; Li SW; Wang BM Biomed Res Int; 2021; 2021():7561645. PubMed ID: 34552988 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database]. Li LY; Wu JX Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532 [No Abstract] [Full Text] [Related]
7. Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. Zhang JJ; Shen Y; Chen XY; Jiang ML; Yuan FH; Xie SL; Zhang J; Xu F Front Endocrinol (Lausanne); 2023; 14():1115890. PubMed ID: 37008925 [TBL] [Abstract][Full Text] [Related]
8. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis. Qi S; Wang C; Li C; Wang P; Liu M Medicine (Baltimore); 2017 Aug; 96(32):e7743. PubMed ID: 28796060 [TBL] [Abstract][Full Text] [Related]
9. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. Chen F; Zhou Y; Wu Z; Li Y; Zhou W; Wang Y Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714 [TBL] [Abstract][Full Text] [Related]
10. Integrative analyses of biomarkers and pathways for adipose tissue after bariatric surgery. Liu Y; Jin J; Chen Y; Chen C; Chen Z; Xu L Adipocyte; 2020 Dec; 9(1):384-400. PubMed ID: 32684073 [TBL] [Abstract][Full Text] [Related]
11. Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study. Fan GH; Wei RL; Wei XY; Zhang CZ; Qi ZT; Xie HY; Zheng SS; Xu X Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):433-451. PubMed ID: 34233850 [TBL] [Abstract][Full Text] [Related]
12. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses. Li G; Li H; Chen Z Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336 [TBL] [Abstract][Full Text] [Related]
13. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. Jiang H; Hu Y; Zhang Z; Chen X; Gao J Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333 [TBL] [Abstract][Full Text] [Related]
14. Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms. Jiang Y; Wang Y; Chen S; Liu Z; Yang H; Jiao Y; Tang L Dis Markers; 2023; 2023():2970429. PubMed ID: 36755803 [TBL] [Abstract][Full Text] [Related]
15. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis. Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q Front Immunol; 2024; 15():1335112. PubMed ID: 38476236 [TBL] [Abstract][Full Text] [Related]
16. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis. Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M Nucleosides Nucleotides Nucleic Acids; 2024; 43(12):1415-1430. PubMed ID: 38319987 [TBL] [Abstract][Full Text] [Related]
17. Integrative analyses of potential biomarkers and pathways for non-obstructive azoospermia. Zhong Y; Chen X; Zhao J; Deng H; Li X; Xie Z; Zhou B; Xian Z; Li X; Luo G; Li H Front Genet; 2022; 13():988047. PubMed ID: 36506310 [No Abstract] [Full Text] [Related]
18. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis. Bai J; Pu X; Zhang Y; Dai E Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363 [TBL] [Abstract][Full Text] [Related]
19. Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis. Ye J; Lin Y; Wang Q; Li Y; Zhao Y; Chen L; Wu Q; Xu C; Zhou C; Sun Y; Ye W; Bai F; Zhou T Front Endocrinol (Lausanne); 2020; 11():601745. PubMed ID: 33324350 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease. Zhang H; Axinbai M; Zhao Y; Wei J; Qu T; Kong J; He Y; Zhang L Eur J Med Res; 2023 Dec; 28(1):605. PubMed ID: 38115130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]